The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae
Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Christian, Schopper [verfasserIn] Doris, Moser [verfasserIn] Alexis, Sabbas [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|
| Erschienen: |
Oxford, UK: Munksgaard International Publishers ; 2003 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
Online-Ressource |
|---|
| Reproduktion: |
2003 ; Blackwell Publishing Journal Backfiles 1879-2005 |
|---|---|
| Übergeordnetes Werk: |
In: Clinical oral implants research - Oxford : Wiley-Blackwell, 1990, 14(2003), 6, Seite 0 |
| Übergeordnetes Werk: |
volume:14 ; year:2003 ; number:6 ; pages:0 |
| Links: |
|---|
| DOI / URN: |
10.1046/j..2003.00959.x |
|---|
| Katalog-ID: |
NLEJ242556892 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLEJ242556892 | ||
| 003 | DE-627 | ||
| 005 | 20210707160831.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 120427s2003 xx |||||o 00| ||und c | ||
| 024 | 7 | |a 10.1046/j..2003.00959.x |2 doi | |
| 035 | |a (DE-627)NLEJ242556892 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 100 | 1 | |a Christian, Schopper |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae |
| 264 | 1 | |a Oxford, UK |b Munksgaard International Publishers |c 2003 | |
| 300 | |a Online-Ressource | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae. | ||
| 533 | |d 2003 |f Blackwell Publishing Journal Backfiles 1879-2005 |7 |2003|||||||||| | ||
| 650 | 4 | |a biomaterial | |
| 700 | 1 | |a Doris, Moser |e verfasserin |4 aut | |
| 700 | 1 | |a Alexis, Sabbas |e verfasserin |4 aut | |
| 700 | 1 | |a Georgios, Lagogiannis |4 oth | |
| 700 | 1 | |a Else, Spassova |4 oth | |
| 700 | 1 | |a Franz, König |4 oth | |
| 700 | 1 | |a Karl, Donath |4 oth | |
| 700 | 1 | |a Rolf, Ewers |4 oth | |
| 773 | 0 | 8 | |i In |t Clinical oral implants research |d Oxford : Wiley-Blackwell, 1990 |g 14(2003), 6, Seite 0 |h Online-Ressource |w (DE-627)NLEJ24392626X |w (DE-600)2027104-9 |x 1600-0501 |7 nnns |
| 773 | 1 | 8 | |g volume:14 |g year:2003 |g number:6 |g pages:0 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1046/j..2003.00959.x |q text/html |x Verlag |z Deutschlandweit zugänglich |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a ZDB-1-DJB | ||
| 912 | |a GBV_NL_ARTICLE | ||
| 951 | |a AR | ||
| 952 | |d 14 |j 2003 |e 6 |h 0 | ||
| author_variant |
s c sc m d md s a sa |
|---|---|
| matchkey_str |
article:16000501:2003----::hfurhdoypttfaroagpriautbeimtrafrhrcntutoos |
| hierarchy_sort_str |
2003 |
| publishDate |
2003 |
| allfields |
10.1046/j..2003.00959.x doi (DE-627)NLEJ242556892 DE-627 ger DE-627 rakwb Christian, Schopper verfasserin aut The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae Oxford, UK Munksgaard International Publishers 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| biomaterial Doris, Moser verfasserin aut Alexis, Sabbas verfasserin aut Georgios, Lagogiannis oth Else, Spassova oth Franz, König oth Karl, Donath oth Rolf, Ewers oth In Clinical oral implants research Oxford : Wiley-Blackwell, 1990 14(2003), 6, Seite 0 Online-Ressource (DE-627)NLEJ24392626X (DE-600)2027104-9 1600-0501 nnns volume:14 year:2003 number:6 pages:0 http://dx.doi.org/10.1046/j..2003.00959.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 14 2003 6 0 |
| spelling |
10.1046/j..2003.00959.x doi (DE-627)NLEJ242556892 DE-627 ger DE-627 rakwb Christian, Schopper verfasserin aut The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae Oxford, UK Munksgaard International Publishers 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| biomaterial Doris, Moser verfasserin aut Alexis, Sabbas verfasserin aut Georgios, Lagogiannis oth Else, Spassova oth Franz, König oth Karl, Donath oth Rolf, Ewers oth In Clinical oral implants research Oxford : Wiley-Blackwell, 1990 14(2003), 6, Seite 0 Online-Ressource (DE-627)NLEJ24392626X (DE-600)2027104-9 1600-0501 nnns volume:14 year:2003 number:6 pages:0 http://dx.doi.org/10.1046/j..2003.00959.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 14 2003 6 0 |
| allfields_unstemmed |
10.1046/j..2003.00959.x doi (DE-627)NLEJ242556892 DE-627 ger DE-627 rakwb Christian, Schopper verfasserin aut The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae Oxford, UK Munksgaard International Publishers 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| biomaterial Doris, Moser verfasserin aut Alexis, Sabbas verfasserin aut Georgios, Lagogiannis oth Else, Spassova oth Franz, König oth Karl, Donath oth Rolf, Ewers oth In Clinical oral implants research Oxford : Wiley-Blackwell, 1990 14(2003), 6, Seite 0 Online-Ressource (DE-627)NLEJ24392626X (DE-600)2027104-9 1600-0501 nnns volume:14 year:2003 number:6 pages:0 http://dx.doi.org/10.1046/j..2003.00959.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 14 2003 6 0 |
| allfieldsGer |
10.1046/j..2003.00959.x doi (DE-627)NLEJ242556892 DE-627 ger DE-627 rakwb Christian, Schopper verfasserin aut The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae Oxford, UK Munksgaard International Publishers 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| biomaterial Doris, Moser verfasserin aut Alexis, Sabbas verfasserin aut Georgios, Lagogiannis oth Else, Spassova oth Franz, König oth Karl, Donath oth Rolf, Ewers oth In Clinical oral implants research Oxford : Wiley-Blackwell, 1990 14(2003), 6, Seite 0 Online-Ressource (DE-627)NLEJ24392626X (DE-600)2027104-9 1600-0501 nnns volume:14 year:2003 number:6 pages:0 http://dx.doi.org/10.1046/j..2003.00959.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 14 2003 6 0 |
| allfieldsSound |
10.1046/j..2003.00959.x doi (DE-627)NLEJ242556892 DE-627 ger DE-627 rakwb Christian, Schopper verfasserin aut The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae Oxford, UK Munksgaard International Publishers 2003 Online-Ressource nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae. 2003 Blackwell Publishing Journal Backfiles 1879-2005 |2003|||||||||| biomaterial Doris, Moser verfasserin aut Alexis, Sabbas verfasserin aut Georgios, Lagogiannis oth Else, Spassova oth Franz, König oth Karl, Donath oth Rolf, Ewers oth In Clinical oral implants research Oxford : Wiley-Blackwell, 1990 14(2003), 6, Seite 0 Online-Ressource (DE-627)NLEJ24392626X (DE-600)2027104-9 1600-0501 nnns volume:14 year:2003 number:6 pages:0 http://dx.doi.org/10.1046/j..2003.00959.x text/html Verlag Deutschlandweit zugänglich Volltext GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE AR 14 2003 6 0 |
| source |
In Clinical oral implants research 14(2003), 6, Seite 0 volume:14 year:2003 number:6 pages:0 |
| sourceStr |
In Clinical oral implants research 14(2003), 6, Seite 0 volume:14 year:2003 number:6 pages:0 |
| format_phy_str_mv |
Article |
| institution |
findex.gbv.de |
| topic_facet |
biomaterial |
| isfreeaccess_bool |
false |
| container_title |
Clinical oral implants research |
| authorswithroles_txt_mv |
Christian, Schopper @@aut@@ Doris, Moser @@aut@@ Alexis, Sabbas @@aut@@ Georgios, Lagogiannis @@oth@@ Else, Spassova @@oth@@ Franz, König @@oth@@ Karl, Donath @@oth@@ Rolf, Ewers @@oth@@ |
| publishDateDaySort_date |
2003-01-01T00:00:00Z |
| hierarchy_top_id |
NLEJ24392626X |
| id |
NLEJ242556892 |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242556892</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707160831.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2003 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1046/j..2003.00959.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242556892</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Christian, Schopper</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Munksgaard International Publishers</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2003</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2003||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">biomaterial</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Doris, Moser</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alexis, Sabbas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Georgios, Lagogiannis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Else, Spassova</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Franz, König</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Karl, Donath</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rolf, Ewers</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Clinical oral implants research</subfield><subfield code="d">Oxford : Wiley-Blackwell, 1990</subfield><subfield code="g">14(2003), 6, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ24392626X</subfield><subfield code="w">(DE-600)2027104-9</subfield><subfield code="x">1600-0501</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2003</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1046/j..2003.00959.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2003</subfield><subfield code="e">6</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| series2 |
Blackwell Publishing Journal Backfiles 1879-2005 |
| author |
Christian, Schopper |
| spellingShingle |
Christian, Schopper misc biomaterial The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae |
| authorStr |
Christian, Schopper |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ24392626X |
| format |
electronic Article |
| delete_txt_mv |
keep |
| author_role |
aut aut aut |
| collection |
NL |
| publishPlace |
Oxford, UK |
| remote_str |
true |
| illustrated |
Not Illustrated |
| issn |
1600-0501 |
| topic_title |
The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae biomaterial |
| publisher |
Munksgaard International Publishers |
| publisherStr |
Munksgaard International Publishers |
| topic |
misc biomaterial |
| topic_unstemmed |
misc biomaterial |
| topic_browse |
misc biomaterial |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
l g lg s e se k f kf d k dk e r er |
| hierarchy_parent_title |
Clinical oral implants research |
| hierarchy_parent_id |
NLEJ24392626X |
| hierarchy_top_title |
Clinical oral implants research |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)NLEJ24392626X (DE-600)2027104-9 |
| title |
The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae |
| ctrlnum |
(DE-627)NLEJ242556892 |
| title_full |
The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae |
| author_sort |
Christian, Schopper |
| journal |
Clinical oral implants research |
| journalStr |
Clinical oral implants research |
| isOA_bool |
false |
| recordtype |
marc |
| publishDateSort |
2003 |
| contenttype_str_mv |
zzz |
| container_start_page |
0 |
| author_browse |
Christian, Schopper Doris, Moser Alexis, Sabbas |
| container_volume |
14 |
| physical |
Online-Ressource |
| format_se |
Elektronische Aufsätze |
| author-letter |
Christian, Schopper |
| doi_str_mv |
10.1046/j..2003.00959.x |
| author2-role |
verfasserin |
| title_sort |
the fluorohydroxyapatite (fha) frios® algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae |
| title_auth |
The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae |
| abstract |
Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae. |
| abstractGer |
Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae. |
| abstract_unstemmed |
Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae. |
| collection_details |
GBV_USEFLAG_U ZDB-1-DJB GBV_NL_ARTICLE |
| container_issue |
6 |
| title_short |
The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae |
| url |
http://dx.doi.org/10.1046/j..2003.00959.x |
| remote_bool |
true |
| author2 |
Doris, Moser Alexis, Sabbas Georgios, Lagogiannis Else, Spassova Franz, König Karl, Donath Rolf, Ewers |
| author2Str |
Doris, Moser Alexis, Sabbas Georgios, Lagogiannis Else, Spassova Franz, König Karl, Donath Rolf, Ewers |
| ppnlink |
NLEJ24392626X |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth |
| doi_str |
10.1046/j..2003.00959.x |
| up_date |
2024-07-06T02:23:16.745Z |
| _version_ |
1803794615367630848 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ242556892</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20210707160831.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">120427s2003 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1046/j..2003.00959.x</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ242556892</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Christian, Schopper</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">The fluorohydroxyapatite (FHA) FRIOS® Algipore® is a suitable biomaterial for the reconstruction of severely atrophic human maxillae</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford, UK</subfield><subfield code="b">Munksgaard International Publishers</subfield><subfield code="c">2003</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Abstract: Grafting of the maxillary sinus is an established treatment modality to provide sufficient bone for the fixation of dental implants. We stated the hypothesis that the porous fluorohydroxyapatitic (FHA) biomaterial FRIOS® Algipore® could be used as a suitable biomaterial for sinus grafting in severely atrophic maxillae. To investigate the accuracy of our hypothesis, 69 trephine specimens from 26 patients who received maxillary sinus grafting with FRIOS® Algipore® were retrieved during the installation of dental implants. The specimens were processed undecalcified and subjected to histomorphological and histomorphometrical examination. After a mean healing time of 7 months, 23.0% (±8.3) new bone had formed around the implanted particles. Bone formation was also evident within the pores of the particles. Statistical analysis indicated that bone formation originated from the sinus floor. Particles provided scaffolding for the promotion of newly formed bone towards apical sinus portions. Mineral dissolution from the walls of the pores was observed prior to and during bone apposition. Thereafter, portions of the particles were resorbed during bone remodeling and replaced by newly formed bone. The present investigation shows that the biomaterial FRIOS® Algipore® is a suitable biomaterial for sinus grafting of severely atrophic maxillae.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="d">2003</subfield><subfield code="f">Blackwell Publishing Journal Backfiles 1879-2005</subfield><subfield code="7">|2003||||||||||</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">biomaterial</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Doris, Moser</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alexis, Sabbas</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Georgios, Lagogiannis</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Else, Spassova</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Franz, König</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Karl, Donath</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rolf, Ewers</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">In</subfield><subfield code="t">Clinical oral implants research</subfield><subfield code="d">Oxford : Wiley-Blackwell, 1990</subfield><subfield code="g">14(2003), 6, Seite 0</subfield><subfield code="h">Online-Ressource</subfield><subfield code="w">(DE-627)NLEJ24392626X</subfield><subfield code="w">(DE-600)2027104-9</subfield><subfield code="x">1600-0501</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:14</subfield><subfield code="g">year:2003</subfield><subfield code="g">number:6</subfield><subfield code="g">pages:0</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://dx.doi.org/10.1046/j..2003.00959.x</subfield><subfield code="q">text/html</subfield><subfield code="x">Verlag</subfield><subfield code="z">Deutschlandweit zugänglich</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DJB</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">14</subfield><subfield code="j">2003</subfield><subfield code="e">6</subfield><subfield code="h">0</subfield></datafield></record></collection>
|
| score |
7.3995686 |